Stockreport

Candel Therapeutics, Inc. (NASDAQ:CADL) most popular amongst individual investors who own 48%, insiders hold 30% [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF The considerable ownership by individual investors in Candel Therapeutics indicates that they collectively have a greater say in management and business strategy A to [Read more]